See C. Phan
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Brain Metastases and Treatment 2
- Lung Cancer Diagnosis and Treatment 1
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Mark L. McCleland (4 shared papers)Tony S.K. Mok (3 shared papers)David S. Shames (4 shared papers)Makoto Nishio (3 shared papers)Francesco Orlandi (3 shared papers)Dustin Smith (3 shared papers)Ticiana A.B. Leal (2 shared papers)David Robert Spigel (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (3 papers)Clinical Lung Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
See C. Phan
14 papers receiving 2.1k citations
See C. Phan's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 796
- Hepatology 163
- Cancer Research 170
- Genetics 120
Countries citing papers authored by See C. Phan
This map shows the geographic impact of See C. Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by See C. Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites See C. Phan more than expected).
Fields of papers citing papers by See C. Phan
This network shows the impact of papers produced by See C. Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by See C. Phan. The network helps show where See C. Phan may publish in the future.
Co-authors
The 25 scholars most cited alongside See C. Phan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) Hit paper breakdown → | 2021 | 614 |
| 2 | Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial Hit paper breakdown → | 2020 | 352 |
| 3 | 2017 | 266 | |
| 4 | 2016 | 254 | |
| 5 | 2021 | 151 | |
| 6 | 2008 | 142 | |
| 7 | 2002 | 134 | |
| 8 | 2022 | 134 | |
| 9 | 2018 | 37 | |
| 10 | 2004 | 36 | |
| 11 | 2016 | 35 | |
| 12 | 2016 | 28 | |
| 13 | Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial. | 2020 | 9 |
| 14 | Results from the phase iii randomized trial of onartuzumab plus erlotinib versus erlotinib in previously treated stage iiib or iv non–small-cell lung cancer: METLung | 2017 | 1 |
About See C. Phan
See C. Phan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Genetics and Cancer Research, having authored 14 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Brain Metastases and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), Glioma Diagnosis and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper) and Lung Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (796 citations), Hepatology (163 citations), Cancer Research (170 citations) and Genetics (120 citations). See C. Phan has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Mark L. McCleland, Tony S.K. Mok, David S. Shames, Makoto Nishio, Francesco Orlandi, Dustin Smith, Ticiana A.B. Leal, David Robert Spigel, Simonetta Mocci and Arnaud Scherpereel. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer, International Journal of Radiation Oncology*Biology*Physics and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.